Literature DB >> 11078265

Quality of life after coronary revascularization in the United States and Canada.

M G Bourassa1, M M Brooks, D B Mark, J Trudel, K M Detre, B Pitt, G S Reeder, W J Rogers, T J Ryan, H C Smith, P L Whitlow, R D Wiens, M A Hlatky.   

Abstract

Cardiac procedures are performed less frequently in Canada than in the United States (US), yet rates of cardiac death and myocardial infarction are similar. We therefore sought to compare long-term symptoms and quality of life in Canadian and American patients undergoing initial coronary revascularization. The 161 patients enrolled in the Bypass Angioplasty Revascularization Investigation at the Montreal Heart Institute were compared with 934 patients enrolled at 7 US sites. Patients' outcomes were documented for 5 years after random assignment to percutaneous transluminal coronary angioplasty or coronary artery bypass graft surgery. Functional status was assessed using the Duke Activity Status Index. Canadian patients were significantly younger and had more angina at study entry. Death and nonfatal myocardial infarction were not significantly different between Canadian and US patients after adjustment for baseline risk. Canadian patients had significantly greater improvements in functional status at 1-year follow-up (Duke Activity Status Index score + 13.5 vs. + 6.0, p = 0.002), but this difference progressively narrowed over 5 years. Angina was equally prevalent in Canadian and US patients at 1 year (16% vs. 19%), but significantly more prevalent in Canadian patients at 5 years (36% vs. 16%, p = 0.001). Repeat revascularization procedures were performed less often over 5 years among Canadian patients (26% vs. 34%, p = 0.08), especially coronary artery bypass graft surgery after initial percutaneous transluminal coronary angioplasty (18% vs. 32%, p = 0.03). These results suggest more anginal symptoms are required in Canada before coronary revascularization, but as a result Canadians receive greater improvements in quality of life after the procedure.

Entities:  

Mesh:

Year:  2000        PMID: 11078265     DOI: 10.1016/s0002-9149(99)90809-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Symptom clusters in patients presenting to the emergency department with possible acute coronary syndrome differ by sex, age, and discharge diagnosis.

Authors:  Anne G Rosenfeld; Elizabeth P Knight; Alana Steffen; Larisa Burke; Mohamud Daya; Holli A DeVon
Journal:  Heart Lung       Date:  2015-06-26       Impact factor: 2.210

2.  Impact of comorbidities by age on symptom presentation for suspected acute coronary syndromes in the emergency department.

Authors:  Larisa A Burke; Anne G Rosenfeld; Mohamud R Daya; Karen M Vuckovic; Jessica K Zegre-Hemsey; Maria Felix Diaz; Josemare Tosta Daiube Santos; Sahereh Mirzaei; Holli A DeVon
Journal:  Eur J Cardiovasc Nurs       Date:  2017-02-15       Impact factor: 3.908

3.  Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents.

Authors:  Michael T Halpern; Michael Lacey; Mary Ann Clark; Miguel A Valentin
Journal:  BMC Cardiovasc Disord       Date:  2004-12-13       Impact factor: 2.298

4.  Sensitivity, specificity, and sex differences in symptoms reported on the 13-item acute coronary syndrome checklist.

Authors:  Holli A Devon; Anne Rosenfeld; Alana D Steffen; Mohamud Daya
Journal:  J Am Heart Assoc       Date:  2014-04-02       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.